Oregon Public Employees Retirement Fund Vertex Pharmaceuticals Inc Transaction History

Oregon Public Employees Retirement Fund

$4.8 Billion
Q2 2024

A detailed history of Oregon Public Employees Retirement Fund transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Oregon Public Employees Retirement Fund holds 22,173 shares of VRTX stock, worth $10.6 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

22,173

Previous 22,073 0.45%

Holding current value

$10.6 Million

Previous $9.23 Million 12.64%

% of portfolio

0.22%

Previous 0.19%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$392.81 - $485.53 $39,281 - $48,553	100 Added 0.45%	22,173 $10.4 Million
Q1 2024 May 02, 2024	SELL	$407.69 - $446.08 $6.28 Million - $6.88 Million	-15,415 Reduced 41.12%	22,073 $9.23 Million
Q4 2023 Feb 12, 2024	SELL	$343.0 - $410.68 $4.31 Million - $5.16 Million	-12,556 Reduced 25.09%	37,488 $15.3 Million
Q3 2023 Oct 26, 2023	SELL	$338.18 - $362.46 $4.88 Million - $5.23 Million	-14,436 Reduced 22.39%	50,044 $17.4 Million
Q2 2023 Jul 26, 2023	SELL	$314.42 - $351.91 $9.46 Million - $10.6 Million	-30,087 Reduced 31.82%	64,480 $22.7 Million
Q1 2023 May 04, 2023	SELL	$283.23 - $323.1 $78,737 - $89,821	-278 Reduced 0.29%	94,567 $29.8 Million
Q4 2022 Jan 26, 2023	BUY	$285.76 - $321.48 $4.16 Million - $4.68 Million	14,571 Added 18.15%	94,845 $0
Q3 2022 Nov 01, 2022	SELL	$273.83 - $305.53 $1.02 Million - $1.14 Million	-3,742 Reduced 4.45%	80,274 $23.2 Million
Q2 2022 Jul 25, 2022	BUY	$234.96 - $292.55 $14.9 Million - $18.6 Million	63,550 Added 310.52%	84,016 $23.7 Million
Q1 2022 Apr 21, 2022	SELL	$221.42 - $260.97 $127,095 - $149,796	-574 Reduced 2.73%	20,466 $5.34 Million
Q4 2021 Feb 01, 2022	SELL	$177.01 - $223.45 $107,799 - $136,081	-609 Reduced 2.81%	21,040 $4.62 Million
Q3 2021 Oct 19, 2021	SELL	$181.39 - $202.99 $53,691 - $60,085	-296 Reduced 1.35%	21,649 $3.93 Million
Q2 2021 Jul 23, 2021	SELL	$187.49 - $221.1 $498,910 - $588,347	-2,661 Reduced 10.81%	21,945 $4.43 Million
Q1 2021 Apr 20, 2021	SELL	$207.02 - $241.31 $24,635 - $28,715	-119 Reduced 0.48%	24,606 $5.29 Million
Q4 2020 Feb 09, 2021	SELL	$207.01 - $276.09 $8.33 Million - $11.1 Million	-40,254 Reduced 61.95%	24,725 $5.84 Million
Q3 2020 Nov 03, 2020	SELL	$255.65 - $303.1 $1.16 Million - $1.37 Million	-4,529 Reduced 6.52%	64,979 $17.7 Million
Q2 2020 Jul 21, 2020	SELL	$225.48 - $295.8 $2.25 Million - $2.95 Million	-9,969 Reduced 12.54%	69,508 $20.2 Million
Q1 2020 Apr 20, 2020	BUY	$199.77 - $247.81 $11 Million - $13.6 Million	55,018 Added 224.94%	79,477 $18.9 Million
Q4 2019 Feb 05, 2020	SELL	$166.71 - $223.91 $237,561 - $319,071	-1,425 Reduced 5.51%	24,459 $5.36 Million
Q3 2019 Nov 07, 2019	SELL	$166.23 - $187.09 $210,613 - $237,043	-1,267 Reduced 4.67%	25,884 $4.39 Million
Q2 2019 Jul 16, 2019	BUY	$164.61 - $190.37 $26,172 - $30,268	159 Added 0.59%	27,151 $4.98 Million
Q1 2019 May 07, 2019	SELL	$163.73 - $194.7 $136,387 - $162,185	-833 Reduced 2.99%	26,992 $4.97 Million
Q4 2018 Feb 07, 2019	SELL	$151.91 - $192.21 $696 Million - $881 Million	-4,583,056 Reduced 99.4%	27,825 $4.61 Million
Q4 2018 Feb 05, 2019	BUY	$151.91 - $192.21 $696 Million - $881 Million	4,583,156 Added 16530.77%	4,610,881 $28,000
Q2 2018 Aug 13, 2018	BUY	$145.72 - $169.96 $165,537 - $193,074	1,136 Added 4.27%	27,725 $4.71 Million
Q1 2018 Apr 12, 2018	BUY	$151.6 - $177.13 $8,034 - $9,387	53 Added 0.2%	26,589 $4.33 Million
Q3 2017 Nov 02, 2017	BUY	$148.13 - $162.24 $3.93 Million - $4.31 Million	26,536	26,536 $4.04 Million

Others Institutions Holding VRTX

# of Institutions

1,707

Shares Held

226M

Call Options Held

1.2M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $123B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oregon Public Employees Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Oregon Public Employees Retirement Fund with notifications on news.

Account

Oregon Public Employees Retirement Fund Vertex Pharmaceuticals Inc Transaction History